Personal information

No personal information available

Activities

Collapse all

Employment (2)

Sørlandet Sykehus HF: Kristiansand, NO

Researcher (Department of Research)
Employment
Source: Self-asserted source
Alen Brkic

Oslo University Hospital: Oslo, Oslo, NO

2023-01-01 to 2026-01-01 | Post-doc (Department of Oncology)
Employment
Source: Self-asserted source
Alen Brkic

Education and qualifications (4)

Norwegian University of Science and Technology: Trondheim, NO

2021 to 2023 | Ph.D. (Faculty of Medicine and Health Sciences)
Education
Source: Self-asserted source
Alen Brkic

University of Agder: Kristiansand, NO

2017 to 2021 | Master's in Public Health Science (Faculty of Health and Sport Sciences )
Education
Source: Self-asserted source
Alen Brkic

Nicolaus Copernicus University: Bydgoszcz, PL

2012 to 2017 | Doctor of Medicine (Faculty of Medicine)
Education
Source: Self-asserted source
Alen Brkic

University of Agder: Kristiansand, NO

2008 to 2011 | Bachelor of Science (Multimedia Technology and Design) (Faculty of Engineering and Science)
Education
Source: Self-asserted source
Alen Brkic

Works (9)

Impact of comorbidities on patient-reported outcomes in psoriatic arthritis: a single centre cohort study

Rheumatology International
2024-06-25 | Journal article
DOI: 10.1007/s00296-024-05632-2
Contributors: Grzegorz Biedroń; Mateusz Wilk; Jarosław Nowakowski; Piotr Kuszmiersz; Zofia Guła; Magdalena Strach; Alen Brkic; Glenn Haugeberg; Mariusz Korkosz
Source: check_circle
Crossref

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs

BMC Health Services Research
2022-12 | Journal article
DOI: 10.1186/s12913-021-07425-w
Part of ISSN: 1472-6963
Source: Self-asserted source
Alen Brkic

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis

Rheumatology and Therapy
2022-12 | Journal article
DOI: 10.1007/s40744-022-00490-5
Contributors: Alen Brkic; Katarzyna Łosińska; Are Hugo Pripp; Mariusz Korkosz; Glenn Haugeberg
Source: check_circle
Crossref

Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis: nationwide registry study

2022-11-18 | Preprint
DOI: 10.1101/2022.11.18.22282501
Contributors: Nina Vibeche Skei; Tom Ivar Lund Nilsen; Siri Tandberg Knoop; Hallie C. Prescott; Stian Lydersen; Randi Marie Mohus; Alen Brkic; Kristin Vardheim Liyanarachi; Erik Solligård; Jan Kristian Damås et al.
Source: check_circle
Crossref

Decentralizing healthcare in Norway to improve patient-centered outpatient clinic management of rheumatoid arthritis – a conceptual model

BMC Rheumatology
2021-12 | Journal article
DOI: 10.1186/s41927-021-00215-1
Contributors: Alen Brkic; Jung G. Kim; Glenn Haugeberg; Andreas P. Diamantopoulos
Source: check_circle
Crossref

Heparanase link between vasculogenesis and angiogenesis as well as a predictive factor of a shorter survival rate

Journal of Physiology and Pharmacology
2019 | Journal article
DOI: 10.26402/jpp.2019.3.13
Source: Self-asserted source
Alen Brkic

Clinical Applicability of Ultrasound in Systemic Large Vessel Vasculitides

Arthritis & Rheumatology
2019-11 | Journal article
DOI: 10.1002/art.41039
Part of ISSN: 2326-5191
Part of ISSN: 2326-5205
Source: Self-asserted source
Alen Brkic

Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients

Bioscience Reports
2018-04-27 | Journal article
DOI: 10.1042/bsr20171657
Part of ISSN: 0144-8463
Part of ISSN: 1573-4935
Source: Self-asserted source
Alen Brkic

Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients

J Physiol Pharmacol
2017 | Journal article
Source: Self-asserted source
Alen Brkic

Peer review (2 reviews for 1 publication/grant)

Review activity for BMJ open. (2)
How many people are using ORCID?